Canada Pension Plan Investment Board’s Tarsus Pharmaceuticals TARS Stock Holding History

Canada Pension Plan Investment Board’s Portfolio TARS Stock Details TARS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.22M	Sell	98,900 -53,300	-35%	-$3.41M	﹤0.01%	777
2026 Q1	$10.7M	Buy	152,200 +1,100	+0.7%	+$76.9K	0.01%	618
2025 Q4	$12.4M	Buy	151,100 +19,800	+15%	+$1.48M	0.01%	596
2025 Q3	$7.8M	Buy	131,300 +122,800	+1,445%	+$6.05M	0.01%	687
2025 Q2	$344K	Buy	8,500 +1,500	+21%	+$67.5K	﹤0.01%	1056
2025 Q1	$360K	Sell	7,000 -75,300	-91%	-$3.72M	﹤0.01%	996
2024 Q4	$4.56M	Buy	82,300 +81,700	+13,617%	+$3.71M	﹤0.01%	729
2024 Q3	$19.7K	Sell	600 -3,600	-86%	-$101K	﹤0.01%	1287
2024 Q2	$114K	Buy	+4,200	New	+$141K	﹤0.01%	1167

Other funds holding TARS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Canada Pension Plan Investment Board's TARS Position: Q2 2026 in Review

Canada Pension Plan Investment Board reduced its Tarsus Pharmaceuticals (TARS) stake by 35% in Q2 2026, selling an estimated $3.41M and leaving 98,900 shares worth $6.22M. The position accounts for ﹤0.01% of the portfolio, ranked #777.

Canada Pension Plan Investment Board first reported a position in TARS in Q2 2024 and has held it in 9 quarters since. The position peaked at $12.4M in Q4 2025. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

Canada Pension Plan Investment Board held 98,900 shares of Tarsus Pharmaceuticals worth $6.22M as of Q2 2026.
Canada Pension Plan Investment Board sold 53,300 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $3.41M.
Tarsus Pharmaceuticals made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #777 holding.
Canada Pension Plan Investment Board first reported a position in Tarsus Pharmaceuticals in Q2 2024 and has held it in 9 quarters since.
Canada Pension Plan Investment Board's Tarsus Pharmaceuticals position peaked at $12.4M in Q4 2025.
257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.